Basic information Safety Supplier Related

Olmesartan

Basic information Safety Supplier Related

Olmesartan Basic information

Product Name:
Olmesartan
Synonyms:
  • 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid
  • Olmesartan
  • 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2’-(1H-tetazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid
  • CS 088
  • Olmesartan Acid
  • Olmesartan Medoxomil-1
  • CS-415
  • Olmesartan (Olmesartan Medoxomil EP Impurity A)
CAS:
144689-24-7
MF:
C24H26N6O3
MW:
446.5
EINECS:
646-413-5
Product Categories:
  • Bases & Related Reagents
  • Intermediates & Fine Chemicals
  • Nucleotides
  • Pharmaceuticals
  • Isotope Labeled Compounds
Mol File:
144689-24-7.mol
More
Less

Olmesartan Chemical Properties

Melting point:
186-188°C
Boiling point:
738.3±70.0 °C(Predicted)
Density 
1.33
storage temp. 
2-8°C
solubility 
DMSO (Slightly), Methanol (Slightly, Heated)
pka
2.39±0.50(Predicted)
form 
powder
color 
white to beige
Stability:
Hygroscopic
CAS DataBase Reference
144689-24-7(CAS DataBase Reference)
More
Less

Safety Information

RTECS 
NI4014100
HS Code 
29339900
Hazardous Substances Data
144689-24-7(Hazardous Substances Data)
More
Less

Olmesartan Usage And Synthesis

Chemical Properties

White Solid

Uses

An labelled angiotensin II receptor antagonist. Used as an anti-hypertensive

Uses

Angiotensin II inhibitor, antihypertensive

Uses

An angiotensin II (AT1) receptor antagonist

Uses

Olmesartan Acid (Olmesartan EP Impurity A) is an angiotensin II receptor antagonist. Used as an anti-hypertensive.

Definition

ChEBI: Olmesartan is a biphenylyltetrazole. It has a role as an antihypertensive agent and an angiotensin receptor antagonist.

General Description

Olmesartan medoxomil, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl-5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate (Benicar, Olmetec) uses the tetrazolering system as its acidic system, which participates inreceptor binding.When administered to a patient, the drugis rapidly and completely bioactivated by ester hydrolysis ofthe medoxomil during absorption from the gastrointestinaltract. Once the prodrug is converted to the active form, virtuallyno further metabolism occurs. In September 2007, theFood and Drug Administration (FDA) approved its use as acombination product with the calcium channel blocker amlodipinefor the management of hypertension. This combinationproduct is sold under the tradename of Azor.

Biochem/physiol Actions

Olmesartan possesses anti-inflammatory and anti-oxidative stress properties. It protects neuronal cells against oligomerized amyloid β (Aβ)-induced cellular senescence.

storage

Store at +4°C

OlmesartanSupplier

Jinan Baizhou Biological Technology Co., Ltd. Gold
Tel
0531-88987162 18615427082
Email
2823799053@qq.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
ShangHai DEMO Chemical Co.,Ltd
Tel
400-021-7337 2355568890
Email
sales@demochem.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com